PARP inhibitors and bevacizumab for treating advanced ovarian cancer

Agency for Care Effectiveness (ACE)
Record ID 32018002593
Project Status: Completed
Year Published: 2022
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Singapore
MeSH Terms
  • Ovarian Neoplasms
  • Bevacizumab
  • Angiogenesis Inhibitors
  • Antineoplastic Combined Chemotherapy Protocols
  • Poly(ADP-ribose) Polymerase Inhibitors
Organisation Name: Agency for Care Effectiveness (ACE)
Contact Address: Ministry of Health, College of Medicine Building, 16 College Road, Singapore 169854
Contact Name:
Contact Email:
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.